Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sawai Group Holdings CoSWGHF 53 3-Year ROIIC % is 25.92 as of Mar. 2026, which is 83% below its 10-year median of 156.98. GuruFocus rates SWGHF with a GF Score™ of 53/100 and a GF Value™ of $15.98. The stock has 3 warning signs investors should review. Among 946 Drug Manufacturers companies, Sawai Group Holdings Co ranks better than 75.05% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sawai Group Holdings Co's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 25.92%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sawai Group Holdings Co's 3-Year ROIIC % or its related term are showing as below:
SWGHF's 3-Year ROIIC % is ranked better than 75.05% of 946
companies
in the Drug Manufacturers industry
Industry Median: 3.61
vs SWGHF: 25.92
Sawai Group Holdings Co (OTCPK:SWGHF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sawai Group Holdings Co 3-Year ROIIC % Related Terms
Sawai Group Holdings Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Group Holdings Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sawai Group Holdings Co 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sawai Group Holdings Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sawai Group Holdings Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sawai Group Holdings Co (SWGHF) has a 3-Year ROIIC % of 25.92 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sawai Group Holdings Co and its competitors. This is 83% below median its historical median of 156.98. Over the past decade, Sawai Group Holdings Co's 3-Year ROIIC % has ranged from 25.92 to 288.04. According to the industry distribution chart, Sawai Group Holdings Co ranks #236 out of 946 companies in the Drug Manufacturers industry, placing it in the top 24.9%.
Is Sawai Group Holdings Co's 3-Year ROIIC % too high?
Sawai Group Holdings Co's current 3-Year ROIIC % of 25.92 is 83% below median its 10-year median of 156.98. Over the past 10 years, this metric has ranged from a low of 25.92 to a high of 288.04. The Drug Manufacturers industry median 3-Year ROIIC % is 3.61. Sawai Group Holdings Co's value of 25.92 is 618% above this industry median. Based on the distribution chart, Sawai Group Holdings Co ranks #236 out of 946 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sawai Group Holdings Co has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Sawai Group Holdings Co's 3-Year ROIIC % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sawai Group Holdings Co ranks #236 out of 946 companies for 3-Year ROIIC %. This places Sawai Group Holdings Co in the top 25% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.61. Sawai Group Holdings Co's value of 25.92 is 618% above this benchmark. Historically, Sawai Group Holdings Co's own 3-Year ROIIC % has ranged from 25.92 to 288.04 over the past decade. While the company's 10-year median is 156.98 vs. the industry median of 3.61, Sawai Group Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.61, based on 946 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sawai Group Holdings Co's current 3-Year ROIIC % of 25.92 is 618% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sawai Group Holdings Co and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sawai Group Holdings Co's current 3-Year ROIIC % is 25.92, which is 83% below median its own 10-year median of 156.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sawai Group Holdings Co stock overvalued right now?
Sawai Group Holdings Co (SWGHF) has a current 3-Year ROIIC % of 25.92. The stock's GF Value™ is $15.98, compared to a current price of $11.52 — trading 27.9% below its estimated fair value. The current 3-Year ROIIC % is 25.92, which is 83% below median its 10-year median of 156.98 and 618% above the Drug Manufacturers industry median of 3.61. Sawai Group Holdings Co's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sawai Group Holdings Co (SWGHF), the current 3-Year ROIIC % is 25.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sawai Group Holdings Co (SWGHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sawai Group Holdings Co stock appears to be undervalued.
The current stock price of $11.52 is trading 27.9% below its estimated GF Value™ of $15.98.
Key valuation signals for SWGHF:
3-Year ROIIC %: 25.92 (83% below median its 10-year median of 156.98)
GF Value™: $15.98 vs. price of $11.52 (27.9% below fair value)
Industry Position: 618% above the Drug Manufacturers median (#236 of 946)
No single metric tells the full story. See the SWGHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sawai Group Holdings Co Ltd is engaged in providing management support or guidance to domestic and foreign companies engaged in businesses related to medical and healthcare services, such as the manufacture and sale of pharmaceutical products and medical equipment, as well as various businesses incidental or related to the same.
53GF Score
Get the complete analysis for SWGHF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SWGHF has been successfully added to your 
